Cargando…
Treatment of distant metastases from follicular cell-derived thyroid cancer
Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metasta...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335791/ https://www.ncbi.nlm.nih.gov/pubmed/25750740 http://dx.doi.org/10.12703/P7-22 |
_version_ | 1782358398171348992 |
---|---|
author | Schlumberger, Martin Leboulleux, Sophie |
author_facet | Schlumberger, Martin Leboulleux, Sophie |
author_sort | Schlumberger, Martin |
collection | PubMed |
description | Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metastases. Two thirds of distant metastases will become refractory to radioiodine at some point, and when there is a significant tumor burden and documented progression on imaging, a treatment with a kinase inhibitor may provide benefits. |
format | Online Article Text |
id | pubmed-4335791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43357912015-03-06 Treatment of distant metastases from follicular cell-derived thyroid cancer Schlumberger, Martin Leboulleux, Sophie F1000Prime Rep Review Article Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment includes levothyroxine administration at suppressive doses, focal treatment modalities with surgery, external radiation therapy and thermal ablation, and radioiodine in patients with uptake of (131)I in their metastases. Two thirds of distant metastases will become refractory to radioiodine at some point, and when there is a significant tumor burden and documented progression on imaging, a treatment with a kinase inhibitor may provide benefits. Faculty of 1000 Ltd 2015-02-03 /pmc/articles/PMC4335791/ /pubmed/25750740 http://dx.doi.org/10.12703/P7-22 Text en © 2015 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Schlumberger, Martin Leboulleux, Sophie Treatment of distant metastases from follicular cell-derived thyroid cancer |
title | Treatment of distant metastases from follicular cell-derived thyroid cancer |
title_full | Treatment of distant metastases from follicular cell-derived thyroid cancer |
title_fullStr | Treatment of distant metastases from follicular cell-derived thyroid cancer |
title_full_unstemmed | Treatment of distant metastases from follicular cell-derived thyroid cancer |
title_short | Treatment of distant metastases from follicular cell-derived thyroid cancer |
title_sort | treatment of distant metastases from follicular cell-derived thyroid cancer |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335791/ https://www.ncbi.nlm.nih.gov/pubmed/25750740 http://dx.doi.org/10.12703/P7-22 |
work_keys_str_mv | AT schlumbergermartin treatmentofdistantmetastasesfromfollicularcellderivedthyroidcancer AT leboulleuxsophie treatmentofdistantmetastasesfromfollicularcellderivedthyroidcancer |